Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2

SIMPLE SUMMARY: The expression of Euchromatin histone lysine methyltransferase 1 and 2 (EHMT1/2) is deregulated in many cancers. Most studies thus far have focused on the downstream targets and pathways regulated by EHMTs. However, the mechanisms that lead to their deregulated expression, and the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ang, Gareth Chin Khye, Gupta, Amogh, Surana, Uttam, Yap, Shirlyn Xue Ling, Taneja, Reshma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221123/
https://www.ncbi.nlm.nih.gov/pubmed/35740522
http://dx.doi.org/10.3390/cancers14122855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221123/
https://www.ncbi.nlm.nih.gov/pubmed/35740522
http://dx.doi.org/10.3390/cancers14122855

Ejemplares similares